Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,181 | 130 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $964.13 | 17 | $0 (2024) |
| ABBVIE INC. | $481.60 | 13 | $0 (2024) |
| GlaxoSmithKline, LLC. | $342.92 | 15 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $272.57 | 5 | $0 (2024) |
| PFIZER INC. | $262.17 | 11 | $0 (2023) |
| Exact Sciences Corporation | $241.29 | 12 | $0 (2024) |
| Lilly USA, LLC | $222.35 | 10 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $206.76 | 11 | $0 (2024) |
| Amgen Inc. | $179.54 | 4 | $0 (2024) |
| Bayer HealthCare Pharmaceuticals Inc. | $157.99 | 6 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $829.74 | 25 | ABBVIE INC. ($208.15) |
| 2023 | $746.85 | 28 | AstraZeneca Pharmaceuticals LP ($274.20) |
| 2022 | $606.39 | 22 | Bayer HealthCare Pharmaceuticals Inc. ($145.63) |
| 2021 | $346.38 | 16 | AbbVie Inc. ($89.83) |
| 2020 | $443.58 | 16 | AstraZeneca Pharmaceuticals LP ($246.57) |
| 2019 | $238.17 | 3 | Teva Pharmaceuticals USA, Inc. ($130.95) |
| 2018 | $339.72 | 9 | Amgen Inc. ($125.00) |
| 2017 | $629.84 | 11 | Boehringer Ingelheim Pharmaceuticals, Inc. ($198.30) |
All Payment Transactions
130 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/09/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $50.72 | General |
| Category: Neurology | ||||||
| 10/08/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: Respiratory | ||||||
| 10/07/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $113.03 | General |
| Category: Respiratory | ||||||
| 09/12/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $93.56 | General |
| 06/13/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: VACCINES | ||||||
| 06/04/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $25.20 | General |
| Category: OUD | ||||||
| 05/22/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: Bone Health | ||||||
| 05/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $88.98 | General |
| Category: NEUROSCIENCE | ||||||
| 05/15/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $21.31 | General |
| Category: Diabetes | ||||||
| 05/09/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $22.60 | General |
| Category: Inflammation | ||||||
| 05/09/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: Oncology | ||||||
| 05/02/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $26.67 | General |
| Category: DIABETES | ||||||
| 04/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: NEUROSCIENCE | ||||||
| 04/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: Diabetes | ||||||
| 04/21/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: Oncology | ||||||
| 04/16/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: PSYCHIATRY | ||||||
| 03/21/2024 | Celgene Corporation | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $21.40 | General |
| Category: Cardiovascular | ||||||
| 03/21/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: Oncology | ||||||
| 03/07/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $21.76 | General |
| Category: PSYCHIATRY | ||||||
| 02/29/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: VIROLOGY | ||||||
| 02/23/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: Oncology | ||||||
| 02/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $30.56 | General |
| Category: DIABETES | ||||||
| 02/19/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $82.40 | General |
| Category: VIROLOGY | ||||||
| 02/15/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: Inflammation | ||||||
| 01/31/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: VACCINES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 150 | 267 | $71,564 | $21,647 |
| 2022 | 4 | 93 | 215 | $49,508 | $17,911 |
| 2021 | 6 | 161 | 320 | $66,400 | $28,703 |
| 2020 | 6 | 217 | 415 | $78,590 | $27,794 |
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 44 | 155 | $58,491 | $16,745 | 28.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 36 | 36 | $9,079 | $4,245 | 46.8% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 33 | 35 | $2,471 | $415.55 | 16.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 37 | 41 | $1,523 | $240.81 | 15.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 49 | 161 | $47,382 | $17,359 | 36.6% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 16 | 18 | $1,206 | $368.50 | 30.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 15 | 16 | $720.00 | $123.92 | 17.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 13 | 20 | $200.00 | $59.64 | 29.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 54 | 175 | $50,400 | $23,032 | 45.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 33 | 51 | $10,965 | $3,770 | 34.4% |
| 99497 | Advance care planning by the physician or other qualified health care professional, first 30 minutes | Office | 2021 | 11 | 12 | $2,028 | $859.28 | 42.4% |
| 71046 | X-ray of chest, 2 views | Office | 2021 | 21 | 26 | $1,647 | $650.00 | 39.5% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 24 | 28 | $1,080 | $307.53 | 28.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 18 | 28 | $280.00 | $84.00 | 30.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 59 | 179 | $38,485 | $13,066 | 34.0% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 50 | 107 | $30,816 | $10,592 | 34.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 26 | 26 | $5,980 | $2,954 | 49.4% |
| 71046 | X-ray of chest, 2 views | Office | 2020 | 24 | 31 | $1,922 | $710.48 | 37.0% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 25 | 29 | $957.00 | $343.64 | 35.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 33 | 43 | $430.00 | $127.20 | 29.6% |
About Dr. Paul Bilder, MD
Dr. Paul Bilder, MD is a Family Medicine healthcare provider based in Cottage Grove, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/07/2007. The National Provider Identifier (NPI) number assigned to this provider is 1275663247.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Paul Bilder, MD has received a total of $4,181 in payments from pharmaceutical and medical device companies, with $829.74 received in 2024. These payments were reported across 130 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($4,181).
As a Medicare-enrolled provider, Bilder has provided services to 621 Medicare beneficiaries, totaling 1,217 services with total Medicare billing of $96,054. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Internal Medicine
- Location Cottage Grove, OR
- Active Since 03/07/2007
- Last Updated 08/29/2024
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1275663247
Products in Payments
- Cologuard Collection Kit (Device) $241.29
- CHANTIX (Drug) $177.45
- Kerendia (Drug) $157.99
- AIRSUPRA (Drug) $156.98
- VRAYLAR (Drug) $152.78
- BREZTRI (Drug) $149.35
- SHINGRIX (Biological) $141.90
- TRULICITY (Drug) $131.68
- AJOVY (Drug) $130.95
- REXULTI (Drug) $129.91
- Repatha (Biological) $125.00
- Vascepa (Drug) $119.39
- MAVYRET (Drug) $117.94
- UBRELVY (Drug) $114.40
- LINZESS (Drug) $95.51
- OFEV (Drug) $95.10
- IMFINZI (Drug) $93.53
- ABILIFY MAINTENA (Drug) $76.85
- BEXSERO (Biological) $75.95
- JARDIANCE (Drug) $72.79
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Cottage Grove
Martha Masciopinto, Md, MD
Family Medicine — Payments: $90,244
Joseph Kalugdan, Md, MD
Family Medicine — Payments: $1,546
John Hawkins, Md, MD
Family Medicine — Payments: $132.66
Dennis Polzin, Do, DO
Family Medicine — Payments: $132.21
Walid Mikhail, Md, MD
Family Medicine — Payments: $119.64
Peter Badroos, Md, Mph, MD, MPH
Family Medicine — Payments: $105.85